Regulation of Follicular Helper T cell Differentiation and Vaccination by IL3
IL3 对滤泡辅助 T 细胞分化和疫苗接种的调节
基本信息
- 批准号:8681872
- 负责人:
- 金额:$ 7.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntibodiesAntibody FormationAntigensAutoantibodiesAutoimmune DiseasesB-LymphocytesBCL6 geneBLR1 geneCD4 Positive T LymphocytesCell Differentiation processCellsCommunicable DiseasesDevelopmentDevelopmental ProcessGene TargetingHelper-Inducer T-LymphocyteIL3 geneImmune responseInterleukin-3Knockout MiceLeadModelingPathway interactionsPhenotypePlayProductionReactionRegulationRegulatory PathwayRoleStructure of germinal center of lymph nodeT cell differentiationT-LymphocyteTestingTranscription Repressor/CorepressorVaccinationchemokine receptorcytokinefightingin vivoinsightmouse modelnovelnovel strategiespublic health relevanceresearch studyvaccine development
项目摘要
DESCRIPTION (provided by applicant): T helper cells are critical for the proper function of the immune response and are essential for helping B cells make antibody. Follicular helper T (TFH) cells are a specialized subset of CD4+ T helper cells whose role is to help B cells produce high affinity antigen-specific antibody, and to promote the germinal center reaction. In the absence of TFH cells, germinal centers and secondary antibody responses cannot develop. However, excessive development of TFH cells is correlated with autoimmune disease. TFH cells are localized to germinal centers within B cell follicles due to their expression of the chemokine receptor CXCR5, and are further characterized by high expression of the transcription repressor BCL6 and the B cell stimulatory cytokine IL-21. Recent studies have shown that BCL6 is the master transcriptional regulator for TFH cells: forced BCL6 expression induces a TFH phenotype in T cells, and TFH cells cannot develop in the absence of BCL6. However, the mechanism for how BCL6 promotes the TFH phenotype is incompletely understood. Using a new BCL6 conditional knockout (cKO) mouse model, we have recently identified novel gene targets of BCL6 in CD4 T cells that are likely to play a role in TFH cell differentiation. In this proposal, we will seek to better define the role of a specific BCL6 target gene, IL-3. Our general hypothesis is that the novel BCL6 target gene IL-3 inhibits TFH function and that blocking IL-3 will increase the antibody response. This hypothesis will be tested in the proposal that follows. INNOVATION: We have identified a previously unknown regulatory pathway for how BCL6 controls TFH cell differentiation and will test this pathway functionally. We will investigate a novel strategy for increasing the efficacy of vaccination for the production of Ab. IMPACT: This study will provide insights into the unique developmental process of TFH cells, and will lead to the delineation of a new regulatory pathway that can be targeted to promote or inhibit TFH function. These experiments will provide information that is critical for understanding the development of the antibody response to fight infectious disease. These studies should aid in the development of vaccines that target TFH cells, and will also impact studies on autoantibody production.
描述(由申请人提供):T辅助细胞对于免疫反应的适当功能至关重要,对于帮助B细胞生成抗体至关重要。卵泡辅助T(TFH)细胞是CD4+ T辅助细胞的专门子集,其作用是帮助B细胞产生高亲和力抗原特异性抗体,并促进生发中心反应。在没有TFH细胞的情况下,生发中心和二抗反应无法发展。但是,TFH细胞的过度发育与自身免疫性疾病有关。 TFH细胞由于趋化因子受体CXCR5的表达而定位于B细胞卵泡内的生发中心,进一步的特征是转录抑制剂BCl6和B细胞刺激性细胞因子IL-21的高表达。最近的研究表明,BCL6是TFH细胞的主要转录调节剂:强迫BCL6表达诱导T细胞中的TFH表型,而在没有BCL6的情况下,TFH细胞无法发展。但是,尚不完全了解BCL6如何促进TFH表型的机制。使用新的BCL6条件敲除(CKO)小鼠模型,我们最近确定了CD4 T细胞中BCl6的新基因靶标,这些基因可能在TFH细胞分化中起作用。在此提案中,我们将寻求更好地定义特定的Bcl6靶基因IL-3的作用。我们的一般假设是,新型的Bcl6靶基因IL-3抑制了TFH功能,而阻断IL-3会增加抗体反应。该假设将在随后的提案中进行检验。创新:我们已经确定了BCl6如何控制TFH细胞分化的先前未知的调节途径,并将在功能上测试该途径。我们将研究一种新的策略,以提高疫苗接种对AB的生产的疗效。影响:这项研究将为TFH细胞的独特发育过程提供见解,并将导致划定一种新的调节途径,该途径可以针对促进或抑制TFH功能。这些实验将提供有关理解对抗传染病的抗体反应发展至关重要的信息。这些研究应有助于开发针对TFH细胞的疫苗,还将影响对自身抗体生产的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander L Dent其他文献
Alexander L Dent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander L Dent', 18)}}的其他基金
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10633229 - 财政年份:2022
- 资助金额:
$ 7.8万 - 项目类别:
Control of ST2+ Treg Development in Allergic Disease by Bcl6 and Sex Hormone Receptors
Bcl6 和性激素受体控制过敏性疾病中 ST2 Treg 的发育
- 批准号:
10535286 - 财政年份:2022
- 资助金额:
$ 7.8万 - 项目类别:
The control of allergic immune responses by follicular regulatory T cells
滤泡调节性 T 细胞对过敏性免疫反应的控制
- 批准号:
10165474 - 财政年份:2017
- 资助金额:
$ 7.8万 - 项目类别:
The Role of Follicular Helper T Cells in HIV Prime Boost Vaccination
滤泡辅助 T 细胞在 HIV 加强疫苗接种中的作用
- 批准号:
8875819 - 财政年份:2014
- 资助金额:
$ 7.8万 - 项目类别:
Regulation of Follicular Helper T cell Differentiation and Vaccination by IL3
IL3 对滤泡辅助 T 细胞分化和疫苗接种的调节
- 批准号:
8853812 - 财政年份:2014
- 资助金额:
$ 7.8万 - 项目类别:
Control of airway inflammation and Th2 differentiation by microRNA 21
microRNA 控制气道炎症和 Th2 分化 21
- 批准号:
8434965 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Development of follicular helper T cell deficient mice
滤泡辅助性T细胞缺陷小鼠的发育
- 批准号:
8289751 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Development of follicular helper T cell deficient mice
滤泡辅助性T细胞缺陷小鼠的发育
- 批准号:
8522152 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Control of autoimmunity by follicular helper T cells and BCL6
滤泡辅助 T 细胞和 BCL6 控制自身免疫
- 批准号:
8072744 - 财政年份:2010
- 资助金额:
$ 7.8万 - 项目类别:
相似国自然基金
人源化小鼠筛选猴痘抗体及机制研究
- 批准号:82373778
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
抗HTNV抗体mRNA修饰MSC在肾综合征出血热治疗中的作用研究
- 批准号:82302487
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向肿瘤内T细胞的双特异性抗体治疗策略研究
- 批准号:82371845
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向DLL3和γδ T细胞的双特异抗体对小细胞肺癌的免疫治疗活性研究
- 批准号:32300783
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
用于完整表征抗体库的软件:从种系和 mRNA 序列组装到其蛋白质结构和靶标的深度学习预测
- 批准号:
10699546 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Anti-medin immunotherapy for vascular aging and related dementias
针对血管老化和相关痴呆的抗 Medin 免疫疗法
- 批准号:
10724869 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
HIPK1: a new immunomodulatory target for SLE
HIPK1:SLE 的新免疫调节靶点
- 批准号:
10647292 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别: